Switch View
© BusinessWire
08.10.2025
ISIN: US69608A1088
Palantir Technologies, Inc.
PLTR
LISTED
NASDAQ
Securities Fraud Investigation Into Palantir Technologies Inc. (PLTR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Palantir Technologies Inc. (“Palantir” or the “Company”) (NASDAQ: PLTR) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY O...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Libtayo® (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation
News Preview
Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence interval: 0.20-0.51; p<0.0001), the primary endpoint of the trial ...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 8, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
08.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 8, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
08.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Deadline Approaching: Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming December 2, 2025 to deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, inclusive (the “Class Period”).
IF YOU ARE AN I...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card
News Preview
STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today provided the following statement in response to a report issued by Glass, Lewis & Co., LLC (“Glass Lewis”) related to STAAR’s pending merger with Alcon (SIX/NYSE: ALC):...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today announced that Glass, Lewis & Co., LLC (“Glass Lewis”), a leading independent proxy advisory firm, has recommended that the shareholders of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) vote “AGAINST” the proposed acquisition of STAAR by Alcon Inc. (“Alc...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US03528H1095
Anixa Biosciences, Inc.
ANIX
LISTED
NASDAQ
Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034
News Preview
Equity Insider
News Commentary
Issued on behalf of GT Biopharma, Inc.
VANCOUVER, BC, Oct. 8, 2025 /PRNewswire/ -...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US92556V1061
Viatris Inc
VTRS
LISTED
NASDAQ
Viatris Named to Forbes' Annual List of the World's Best Employers for the Fifth Year in a Row
News Preview
PITTSBURGH, Oct. 8, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that it has been named to Forbes' list of World's Best Employers 2025. This is the fifth year in a row that Viatris has received this recognition, which is presented by Forbes and Statista, the world...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US03528H1095
Anixa Biosciences, Inc.
ANIX
LISTED
NASDAQ
Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034
News Preview
Equity Insider
News Commentary
Issued on behalf of GT Biopharma, Inc.
VANCOUVER, BC, Oct. 8, 2025 /PRNewswire/ -...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US03528H1095
Anixa Biosciences, Inc.
ANIX
LISTED
NASDAQ
Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034
News Preview
Equity Insider
News Commentary
Issued on behalf of GT Biopharma, Inc.
VANCOUVER, BC, Oct. 8, 2025 /CNW/ -- Ohio...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US69608A1088
Palantir Technologies, Inc.
PLTR
LISTED
NASDAQ
Palantir Technologies Inc. (PLTR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Palantir Technologies Inc. (“Palantir” or the “Company”) (NASDAQ: PLTR) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PALANTIR TECHNOLOGIES INC. (PLTR), CONTACT THE LAW OFFICES OF HOWARD G. SMI...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
08.10.2025
ISIN: GB00BYMT0J19
LivaNova PLC
LIVN
LISTED
NASDAQ
LivaNova to Announce Third-Quarter 2025 Results
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its third-quarter 2025 results on Wed., Nov. 5, 2025, at 1 p.m. London time (8 a.m. Eastern Standard Time). The Company will release its third-quarter 2025 results prior to the call.
The audiocast will be accessible at www.livanova.co...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: GB00BMX86B70
Haleon PLC
HLN
LISTED
LSE
Haleon Selects Salesforce Agentforce Life Sciences Cloud for Customer Engagement to Improve Engagement with Pharmacies and Healthcare Professionals with AI
News Preview
Haleon plc (LSE/NYSE:HLN), a leading global consumer company that specialises in everyday health and Salesforce (NYSE:CRM), the world’s #1 AI CRM, today announced that Haleon will leverage Salesforce to drive more effective engagement with pharmacies and healthcare professionals worldwide.
This press release features multimedia. View the full rel...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US7665596034
Rigel Pharmaceuticals, Inc.
RIGL
LISTED
NASDAQ
Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS
News Preview
Dose expansion phase will determine the recommended Phase 2 dose of R289 for patients with transfusion dependent R/R lower-risk MDS
SOUTH SAN FRANCISCO, Calif., Oct. 8, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechn...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BIOVAXYS APPOINTS FORMER SANOFI VACCINES EXECUTIVE TO BOARD OF DIRECTORS
News Preview
VANCOUVER, BC, Oct. 8, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB:BVAXF) ("BioVaxys" or "Company") is pleased to announce that James Tartaglia, PhD, a former top R&D and commercial development executive with Sanofi Vaccines, has been appointed to the BioVaxys Board of Directors. Dr...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US9216591084
Vanda Pharmaceuticals Inc
VNDA
LISTED
NASDAQ
Monumental Sports & Entertainment Taps D.C.'s Own Vanda Pharmaceuticals as Founding Partner to Help Drive the Creation of Brand-New Downtown Arena
News Preview
Multiyear agreement includes exclusive Monumental Sports Network studio entitlement, activations across Capitals, Wizards, and Mystics, and deep integration via community and media platforms
For photos of the new Vanda Pharmaceuticals Studio...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BIOVAXYS APPOINTS FORMER SANOFI VACCINES EXECUTIVE TO BOARD OF DIRECTORS
News Preview
VANCOUVER, BC, Oct. 8, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB:BVAXF) ("BioVaxys" or "Company") is pleased to announce that James Tartaglia, PhD, a former top R&D and commercial development executive with Sanofi Vaccines, has been appointed to the BioVaxys Board of Directo...
Themefolio
Profiler
Peergroup
© Newsfile
08.10.2025
ISIN: CA71716H1082
PharmaTher Holdings Ltd.
PHRM
LISTED
CSE
PharmaTher Provides Update on Ketamine Program for LID-Parkinson's Disease
News Preview
Phase 3 program targeting a potential US$2.2B U.S. market opportunity505(b)(2) regulatory path leveraging prior human data to reduce risk, cost, and timeFDA-reviewed CMC package validated through prior ANDA approvalPatent coverage to 2036 for ketamine in Parkinson's and related motor disordersActive pharmaceutical partnering discussionsUpcoming cat...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Incyte to Report Third Quarter Financial Results
News Preview
Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 28, 2025.
The schedule for the press release and conference call/webcast is as follows:
Q3 2025 Press Release: October 28, 2025 at 7:00 a.m. ET
Q3 2025 Conference Call: October 28,...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced pioneering scientific contributions that will be presented at the American Society of Human Genetics (ASHG) Annual Meeting.
At ASHG, GeneDx will unveil research findings drawn from GeneDx Infinity™, a dataset of nearly one million exom...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) and Toxys today announced a collaboration that offers Charles River’s clients access to ReproTracker®, a state-of-the-art human stem cell-based in vitro assay that rapidly and reliably identifies developmental toxicity hazards of new drugs and chemicals.
This press release features multim...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema
News Preview
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced the initiation of the Phase 3 ORBIT-EXPANSE long-term trial of navenibart in people living with hereditary angioedema (HAE).
“The initiation of ORBIT-EXPANSE marks exciting prog...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US04963C2098
AtriCure Inc
ATRC
LISTED
NASDAQ
AtriCure to Announce Third Quarter 2025 Financial Results
News Preview
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its third quarter 2025 financial results on Wednesday, October 29, 2025.
AtriCure will host an audio webcast at 4:...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US68236V3024
ETHZilla Corporation
ETHZ
LISTED
NASDAQ
ETHZilla Announces Appointment of Jason New to Board of Directors
News Preview
PALM BEACH, Fla., Oct. 8, 2025 /PRNewswire/ -- ETHZilla Corporation (Nasdaq: ETHZ) ("ETHZilla" or the "Company"), today announced that Jason New, Vice Chairman of Investment Banking at Lazard, has been appointed as a member of its Board of Directors, effective immediately....
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US0043971052
Accuray Inc
ARAY
LISTED
NASDAQ
Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System
News Preview
5D Clinics and Joint Venture Partner Icon Group Make Strides in Delivering on Commitment to Increasing Access to World-class Radiation Treatments for More Communities Across Australia.
MADISON, Wis., Oct. 8, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARA...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases
News Preview
Gorilla® Pilon Fusion Plating System Introduced for Complex Ankle Fusions
Phantom® TTC Trauma Nail Enhances Treatment Options for Complex Hindfoot Injuries
WARSAW, Ind., Oct. 8, 2025 /PRNewswire/ -- Zimmer Biom...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US89532M1018
Trevi Therapeutics Inc
TRVI
LISTED
NASDAQ
Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting
News Preview
Professor Philip Molyneaux will give an oral presentation on the key efficacy and safety results from the Phase 2b CORAL trial of nalbuphine ER for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF)
Associate Professor Imran Sati...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US64135M1053
Neurogene Inc
NGNE
LISTED
NASDAQ
Neurogene to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the H.C. Wainwright Genetic Medicines Virtual Conference.
Format: Management will participate in a fireside chat and...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
Invitation: Sobi's Q3 2025 report
News Preview
STOCKHOLM, Oct. 8, 2025 /PRNewswire/ -- Sobi plans to publish its report for the third quarter of 2025 on 23 October 2025 at 08:00 CEST.
Investors, analysts, and the media are invited to a conference call on the same day at 13:00 CEST, 12:00 BST, and 07:00 EDT. The call will include a presentation...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US46120E6023
Intuitive Surgical Inc
ISRG
LISTED
NASDAQ
Intuitive expands AI and advanced imaging integration in Ion Endoluminal System
News Preview
FDA-cleared software release enhances navigation and broadens access to advanced imaging for lung biopsy procedures FDA-cleared software release enhances navigation and broadens access to advanced imaging for lung biopsy procedures ...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US69404D1081
Pacific Biosciences of California Inc
PACB
LISTED
NASDAQ
Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity
News Preview
Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio’s Revio system, powering one of the largest studies of healthy aging to date Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio’s Revio system, powering one of the largest studies of healthy aging to date...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures
News Preview
First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States
GALWAY, Ireland, Oct. 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced the start of the...
Themefolio
Profiler
Peergroup
© Newsfile
08.10.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
News Preview
$4 million upfront with up to additional $12 million of potential aggregate gross proceeds upon the exercise in full of warrantsWhite Bear Lake, Minnesota--(Newsfile Corp. - October 8, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, toda...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US3773221029
Glaukos Corp
GKOS
LISTED
NYSE
Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29
News Preview
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release third quarter 2025 financial results after the market close on Wednesday, October 29, 2025. The company’s management will discuss the result...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: CA1380357048
Canopy Growth Corp
CGC
LISTED
NASDAQ
Canopy Growth Announces DOJA as Dedicated Canadian Medical Facility
News Preview
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced that its DOJA facility in Kelowna, British Columbia is now operating exclusively as a medical cultivation site supporting the Company’s Spectrum The...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US30063P1057
Exact Sciences Corp
EXAS
LISTED
NASDAQ
Exact Sciences Schedules Third Quarter 2025 Earnings Call
News Preview
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its third quarter 2025 financial results after the close of the U.S. financial markets on November 3, 2025. Following the release, company management will host a webcast and conference call at 5 p.m. E...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD and Opentrons Collaborate to Accelerate Single-Cell Multiomics Discoveries with Robotic Automation
News Preview
FRANKLIN LAKES, N.J., Oct. 8, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, today announced a multi-year collaboratio...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US67092M2089
Nutriband Inc.
NTRB
LISTED
NASDAQ
Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology
News Preview
Provisional patent application...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US4579852082
Integra Lifesciences Holdings Corp
IART
LISTED
NASDAQ
Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting
News Preview
Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US57777K1060
MaxCyte Inc
MXCT
LISTED
NASDAQ
MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
ROCKVILLE, Md., Oct. 08, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the third quarter 2025 af...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: CA46604F1099
Izotropic Corporation
IZO
LISTED
CSE
Izotropic Marks Breast Cancer Awareness Month by Highlighting Gaps in Care and the Need for IzoView Breast CT
News Preview
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US09073N3008
Streamex Exchange Corp.
STEX
LISTED
NASDAQ
Streamex Corp. (NASDAQ: STEX) to Participate in the 28th Annual Needham Growth Conference
News Preview
LOS ANGELES, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a vertically integrated commodity tokenization company, today announced that members of its executive management team will participate in the 28th Annual Needham Growth Conference, to be held January 13–14, 2026, in New York City....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US92243A2006
Vaxart Inc
VXRT
LISTED
NASDAQ
Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it will present research highlighting its advances in its norovirus and...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US15713L1098
CervoMed Inc.
CRVO
LISTED
NASDAQ
CervoMed Announces New Data from Phase 2b Trial Demonstrating Neflamapimod's Potential as a Treatment for Dementia with Lewy Bodies
News Preview
Significant improvement relative to placebo on primary outcome measure, change in Clinical Dementia Rating Sum of Boxes (CDR-SB), demonstrated in a within-subject analysis in participants with low likelihood of having Alzheimer’s disease (AD) co-pathology...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US03843E1047
Aquestive Therapeutics Inc
AQST
LISTED
NASDAQ
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™
News Preview
WARREN, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the United States Patent and Trademark Office (USPTO) has...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US67092M2089
Nutriband Inc.
NTRB
LISTED
NASDAQ
Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference
News Preview
Conference presentation...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: AU000000IMC7
Immuron Limited
IMC
LISTED
ASX
Immuron Submits IMM-529 IND to FDA
News Preview
Key Points...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
08.10.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies (OTC PINK:MDCE) Initiates Preparatory Phase for Self-Conducted Research Studies on AI Mental Health and Preventive Biometrics Modules
News Preview
MESA, ARIZONA / ACCESS Newswire / October 8, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), an emerging innovator in AI-powered preventive healthcare, announced that it is preparing to conduct internal, non-clinical research studies on the consumer-facing components of its AI health platform - the Mental Health & Micro-Expression Tracke...
Themefolio
Profiler
Peergroup
© Newsfile
08.10.2025
ISIN: CH1129677105
Medmix AG
MEDX
LISTED
SIX
medmix Wins One of the Largest New Beauty Businesses in Company History and Strengthens Position in Key Global Beauty Markets with Facility Extensions
News Preview
Baar, Switzerland--(Newsfile Corp. - October 8, 2025) - medmix AGNeuhofstrasse 20CH-6430 Baarcommunications@medmix.com www.medmix.swissMEDIA RELEASEDOWNLOAD MEDIA RELEASE medmix Wins One of the Largest New Beauty Businesses in Company History and Strengthens Position in Key Global Beauty Markets with Facility Extensions me...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US98937L1052
Zenas BioPharma, Inc.
ZBIO
LISTED
NASDAQ
Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multiple Sclerosis
News Preview
- Orelabrutinib, a highly selective CNS-penetrant, oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with best-in-class potential now in Phase 3 development for progressive forms of Multiple Sclerosis (MS) - ...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
08.10.2025
ISIN: US03835L2079
Aptevo Therapeutics Inc.
APVO
LISTED
NASDAQ
Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter
News Preview
SEATTLE, WASHINGTON / ACCESS Newswire / October 8, 2025 / Aptevo Therapeutics ("Aptevo" or the "Company") (Nasdaq:APVO), a clinical-stage biotechnology company developing novel bispecific and trispecific immuno-oncology therapeutics, today announced its participation in upcoming key financial, industry, scientific and medical co...
Themefolio
Profiler
Peergroup
© EQS Newswire
08.10.2025
ISIN: CH1251125998
Relief Therapeutics Holding SA
RLF
LISTED
SIX
Relief Therapeutics and NeuroX, Successor to MindMaze, Sign Definitive Agreement for Business Combination
News Preview
Relief Therapeutics and NeuroX, Successor to MindMaze, Sign Definitive Agreement for Business Combination
Companies sign definitive agreement following previously announced binding term sheet
Transaction to create an expanded, SIX-listed, commercial-stage, AI-driven, scalable health tech company
Combined company to be renamed MindMaze Therapeuti......
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US90400D1081
Ultragenyx Pharmaceutical Inc
RARE
LISTED
NASDAQ
Ultragenyx annuncia l'approvazione da parte dell'AIFA (Agenzia Italiana del Farmaco) del rimborso di Evkeeza® (evinacumab) per i pazienti pediatrici di età pari a 6 mesi con ipercolesterolemia familiare omozigote (HoFH)
News Preview
MILANO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), azienda biofarmaceutica focalizzata sullo sviluppo e la commercializzazione di nuove terapie per malattie genetiche rare e ultra-rare, ha annunciato oggi che l'AIFA (Agenzia Italiana del Farmaco) ha esteso il rimborso di Evkeeza® (evinacumab) per il trattamen...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors
News Preview
AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors
News Preview
AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: KYG1996C1006
CARsgen Therapeutics Holdings Limited
2171
LISTED
HKSE
CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology
News Preview
SHANGHAI, Oct. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of CT071 (an autologous CAR T-cell product targeting GPRC5D) for the treatment of relapsed/refractory multiple myeloma (R/...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
08.10.2025
ISIN: GB0034330679
Angle plc
AGL
LISTED
AIMX
Angle PLC Announces Strategy Update
News Preview
Appointment of Executive Chairman, proposed change of name and strategy updateCompany to pursue revised strategy and name change to CelLBxHealth plcDr. Jan Groen, the current Non-Executive Chairman and recognised oncology diagnostic industry veteran, to lead company as Executive ChairmanRevised strategy to sharpen focus on the provision of industry...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: US29664W1053
Esperion Therapeutics Inc
ESPR
LISTED
NASDAQ
Esperion Announces Pricing of Public Offering of Common Stock
News Preview
ANN ARBOR, Mich., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (“Esperion”) (Nasdaq: ESPR), a commercial stage biopharmaceutical company that focuses on developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C), today announc...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US69608A1088
Palantir Technologies, Inc.
PLTR
LISTED
NASDAQ
Securities Fraud Investigation Into Palantir Technologies Inc. (PLTR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Palantir Technologies Inc. (“Palantir” or the “Company”) (NASDAQ: PLTR) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON PALANTIR TECHNOLOGIES INC. (PLTR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
